Privacy Policy

This privacy policy will explain how AMR.Solutions uses the personal data we collect from you when you use our website.

Topics:

  • What data do we collect?
  • How do we collect your data?
  • How will we use your data?
  • How do we store your data?
  • Marketing
  • What are your data protection rights?
  • What are cookies?
  • How do we use cookies?
  • What types of cookies do we use?
  • How to manage your cookies
  • Privacy policies of other websites
  • Changes to our privacy policy
  • How to contact us

What data do we collect?

AMR.Solutions collects the following data:

  • Personal identification information: Name and email address

How do we collect your data?

You directly provide AMR.Solutions with most of the data we collect. We collect data and process data when you:

  • Signup for our newsletter
  • Voluntarily complete a survey we send to you.
  • Use or view our website via your browser’s cookies.

AMR.Solutions may also receive your data indirectly from the following sources:

  • Mailchimp, the vendor who delivers our newsletter to you

How will we use your data?

AMR.Solutions collects your data so that we can:

  • Manage your newsletter subscription.

We do not share your name or email address with third parties.

How do we store your data?

AMR.Solutions securely stores your data at the data center(s) hosted by Mailchimp. You can read about their privacy policy and their data security practices.

AMR.Solutions will keep your name and email address until you tell us to delete it. You can delete your name and email address by contacting us at privacy@amr.solutions.

Marketing

We do not send you marketing materials.

What are your data protection rights?

AMR.Solutions would like to make sure you are fully aware of all of your data protection rights. Every user is entitled to the following:

The right to access – You have the right to request AMR.Solutions for copies of your personal data. We may charge you a small fee for this service.

The right to rectification – You have the right to request that AMR.Solutions correct any information you believe is inaccurate. You also have the right to request AMR.Solutions to complete the information you believe is incomplete.

The right to erasure – You have the right to request that AMR.Solutions erase your personal data, under certain conditions.

The right to restrict processing – You have the right to request that AMR.Solutions restrict the processing of your personal data, under certain conditions.

The right to object to processing – You have the right to object to AMR.Solutions’s processing of your personal data, under certain conditions.

The right to data portability – You have the right to request that AMR.Solutions transfer the data that we have collected to another organization, or directly to you, under certain conditions.

If you make a request, we have one month to respond to you. If you would like to exercise any of these rights, please contact us at our email at privacy@amr.solutions.

Cookies

Cookies are text files placed on your computer to collect standard Internet log information and visitor behavior information. When you visit our websites, we may collect information from you automatically through cookies or similar technology

For further information, visit https://allaboutcookies.org/.

How do we use cookies?

AMR.Solutions uses cookies in a range of ways to improve your experience on our website, including:

  • Understanding how you use our website
  • Understanding your location at the country or regional level.

What types of cookies do we use?

There are a number of different types of cookies, however, our website uses:

  • Functionality – AMR.Solutions uses these cookies so that we recognize you on our website and remember your previously selected preferences. These could include what language you prefer and location you are in. A mix of first-party and third-party cookies are used.

How to manage cookies

You can set your browser not to accept cookies, and the above website tells you how to remove cookies from your browser. However, in a few cases, some of our website features may not function as a result.

Privacy policies of other websites

The AMR.Solutions website contains links to other websites. Our privacy policy applies only to our website, so if you click on a link to another website, you should read their privacy policy.

Changes to our privacy policy

AMR.Solutions keeps its privacy policy under regular review and places any updates on this web page. This privacy policy was last updated on August 7, 2023. The policy was last re-reviewed on 9 July 2025 and no changes were found necessary.

How to contact us

If you have any questions about AMR.Solutions’s privacy policy, the data we hold on you, or you would like to exercise one of your data protection rights, please do not hesitate to contact us by email at privacy@amr.solutions.

Share

PACE: GBP 6m call for early-stage Gram-negative products

Dear All, PACE (Pathways to Antimicrobial Clinical Efficacy), a large UK-based public-private funder, have announced a £6 million funding round for projects in the hit-to-lead and lead optimization stages. The call is for antibacterial projects that target WHO priority Gram-negative pathogens (Enterobacteriaceae, A. baumannii and P. aeruginosa; see the AMR.Solutions summary of the priority pathogen

EU’s €253 million, 10-year One Health AMR (OHAMR) Initiative

Dear All, The EU have today announced the European Partnership on One Health AMR (OHAMR), a major AMR funding initiative that will run for 10 years (press release, webpage)! As a bit of background, the EU have invested more than EUR 1 billion in hundreds of AMR-focused projects over the past ~15 years. From my

De-risking vaccine development: Insights spanning decades of experience

Dear All (with thanks to Vega Masignani for co-authoring this newsletter), While the work needed to create new antibacterial agents is the primary topic of this newsletter, the need for vaccines of all types is definitely part of our community’s joint remit. As discussed in the 29 Mar 2021 newsletter (“Vaccines to turn back the

20 Nov 2025: BARDA Innovation Symposium

Dear All, I am pleased to learn that BARDA is holding a one-day innovation symposium on 20 Nov 2025. As you know, BARDA is a consistently creative funder of diverse medical countermeasures, including new antibiotics. For background, see these prior newsletters: 22 Jul 2025 newsletter: “BARDA RFP: Antibiotic for HABP/VABP or Bloodstream Infection” 5 Nov

Scroll to Top